Royal Bank of Canada
UTMD icon

Royal Bank of Canada’s Utah Medical Products UTMD Stock Holding History

Royal Bank of Canada’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$717K Buy
11,560
+4,460
+63% +$281K ﹤0.01% 3869
2025
Q4 		$398K Buy
7,100
+575
+9% +$33.3K ﹤0.01% 4342
2025
Q3 		$411K Buy
6,525
+291
+5% +$17.2K ﹤0.01% 4626
2025
Q2 		$355K Buy
6,234
+2,517
+68% +$137K ﹤0.01% 4727
2025
Q1 		$208K Sell
3,717
-1,838
-33% -$110K ﹤0.01% 4674
2024
Q4 		$341K Sell
5,555
-129
-2% -$8.34K ﹤0.01% 4387
2024
Q3 		$382K Buy
5,684
+2,865
+102% +$194K ﹤0.01% 4316
2024
Q2 		$188K Buy
2,819
+1,542
+121% +$105K ﹤0.01% 4821
2024
Q1 		$90K Sell
1,277
-1,117
-47% -$83.8K ﹤0.01% 5247
2023
Q4 		$202K Buy
2,394
+719
+43% +$59.6K ﹤0.01% 5094
2023
Q3 		$144K Sell
1,675
-2,702
-62% -$249K ﹤0.01% 5098
2023
Q2 		$408K Buy
4,377
+51
+1% +$4.81K ﹤0.01% 4110
2023
Q1 		$409K Sell
4,326
-207
-5% -$19K ﹤0.01% 4037
2022
Q4 		$455K Buy
4,533
+355
+8% +$32.4K ﹤0.01% 4199
2022
Q3 		$358K Buy
4,178
+139
+3% +$12.3K ﹤0.01% 4298
2022
Q2 		$347K Sell
4,039
-334
-8% -$28.5K ﹤0.01% 4362
2022
Q1 		$393K Sell
4,373
-677
-13% -$62.3K ﹤0.01% 4472
2021
Q4 		$505K Buy
5,050
+374
+8% +$38.2K ﹤0.01% 4437
2021
Q3 		$435K Buy
4,676
+422
+10% +$37.3K ﹤0.01% 4481
2021
Q2 		$362K Buy
4,254
+1,629
+62% +$141K ﹤0.01% 4555
2021
Q1 		$227K Buy
2,625
+259
+11% +$22.8K ﹤0.01% 4844
2020
Q4 		$199K Buy
2,366
+1,214
+105% +$103K ﹤0.01% 4859
2020
Q3 		$92K Buy
1,152
+252
+28% +$20.9K ﹤0.01% 5019
2020
Q2 		$80K Hold
900
– – ﹤0.01% 4990
2020
Q1 		$85K Sell
900
-267
-23% -$24.8K ﹤0.01% 4872
2019
Q4 		$126K Buy
1,167
+267
+30% +$27.1K ﹤0.01% 4954
2019
Q3 		$86K Sell
900
-100
-10% -$9.29K ﹤0.01% 4874
2019
Q2 		$96K Hold
1,000
– – ﹤0.01% 4901
2019
Q1 		$88K Hold
1,000
– – ﹤0.01% 4854
2018
Q4 		$83K Sell
1,000
-81
-7% -$7.13K ﹤0.01% 4818
2018
Q3 		$102K Buy
1,081
+81
+8% +$7.74K ﹤0.01% 4854
2018
Q2 		$110K Hold
1,000
– – ﹤0.01% 4762
2018
Q1 		$99K Sell
1,000
-29
-3% -$2.59K ﹤0.01% 4704
2017
Q4 		$83K Sell
1,029
-290
-22% -$22.6K ﹤0.01% 4920
2017
Q3 		$97K Buy
1,319
+169
+15% +$12.2K ﹤0.01% 5039
2017
Q2 		$83K Sell
1,150
-257
-18% -$16.9K ﹤0.01% 4864
2017
Q1 		$88K Buy
1,407
+975
+226% +$61.4K ﹤0.01% 4831
2016
Q4 		$31K Sell
432
-18
-4% -$1.17K ﹤0.01% 5528
2016
Q3 		$27K Buy
450
+200
+80% +$12.7K ﹤0.01% 5429
2016
Q2 		$16K Hold
250
– – ﹤0.01% 5588
2016
Q1 		$16K Sell
250
-13
-5% -$767 ﹤0.01% 5576
2015
Q4 		$15K Sell
263
-172
-40% -$9.75K ﹤0.01% 5838
2015
Q3 		$23K Sell
435
-142
-25% -$7.74K ﹤0.01% 5517
2015
Q2 		$34K Buy
577
+300
+108% +$16.9K ﹤0.01% 5429
2015
Q1 		$17K Buy
277
+27
+11% +$1.59K ﹤0.01% 5410
2014
Q4 		$15K Hold
250
– – ﹤0.01% 5491
2014
Q3 		$12K Sell
250
-50
-17% -$2.54K ﹤0.01% 5436
2014
Q2 		$15K Hold
300
– – ﹤0.01% 5290
2014
Q1 		$17K Sell
300
-100
-25% -$5.46K ﹤0.01% 5265
2013
Q4 		$23K Sell
400
-98
-20% -$5.38K ﹤0.01% 5203
2013
Q3 		$30K Buy
498
+98
+25% +$5.35K ﹤0.01% 5027
2013
Q2 		$22K Buy
+400
New +$18.8K ﹤0.01% 4995

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's UTMD Position: Q1 2026 in Review

Royal Bank of Canada increased its Utah Medical Products (UTMD) stake by 63% in Q1 2026, buying an estimated $281K and bringing the position to 11,560 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #3869.

Royal Bank of Canada first reported a position in UTMD in Q2 2013 and has held it in 52 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Royal Bank of Canada held 11,560 shares of Utah Medical Products worth $717K as of Q1 2026.
  • Royal Bank of Canada bought 4,460 Utah Medical Products shares in Q1 2026, an estimated $281K.
  • Utah Medical Products made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3869 holding.
  • Royal Bank of Canada first reported a position in Utah Medical Products in Q2 2013 and has held it in 52 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.